193 related articles for article (PubMed ID: 28242140)
1. MRI-guided lung SBRT: Present and future developments.
Menten MJ; Wetscherek A; Fast MF
Phys Med; 2017 Dec; 44():139-149. PubMed ID: 28242140
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
Ma TM; Lamb JM; Casado M; Wang X; Basehart TV; Yang Y; Low D; Sheng K; Agazaryan N; Nickols NG; Cao M; Steinberg ML; Kishan AU
BMC Cancer; 2021 May; 21(1):538. PubMed ID: 33975579
[TBL] [Abstract][Full Text] [Related]
3. Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI.
Saito AI; Olivier KR; Li JG; Liu C; Newlin HE; Schmalfuss I; Kyogoku S; Dempsey JF
J Appl Clin Med Phys; 2014 May; 15(3):4434. PubMed ID: 24892328
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
[TBL] [Abstract][Full Text] [Related]
5. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
6. Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems.
Freedman JN; Bainbridge HE; Nill S; Collins DJ; Kachelrieß M; Leach MO; McDonald F; Oelfke U; Wetscherek A
Phys Med Biol; 2019 May; 64(11):115005. PubMed ID: 30844775
[TBL] [Abstract][Full Text] [Related]
7. Technical Note: Imaging dose resulting from optimized procedures with limited-angle intrafractional verification system during stereotactic body radiation therapy lung treatment.
Ding GX; Zhang Y; Ren L
Med Phys; 2019 Jun; 46(6):2709-2715. PubMed ID: 30937910
[TBL] [Abstract][Full Text] [Related]
8. Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.
Han C; Sampath S; Schultheisss TE; Wong JYC
Med Dosim; 2017 Summer; 42(2):116-121. PubMed ID: 28433482
[TBL] [Abstract][Full Text] [Related]
9. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
[TBL] [Abstract][Full Text] [Related]
10. Emerging technologies in stereotactic body radiotherapy.
Ma L; Wang L; Tseng CL; Sahgal A
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S12. PubMed ID: 28917250
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Accuracy of Bioluminescence Image-Guided Stereotactic Body Radiation Therapy of Orthotopic Pancreatic Tumors Using a Small Animal Irradiator.
Rapic S; Samuel T; Lindsay PE; Ansell S; Weersink RA; DaCosta RS
Radiat Res; 2022 Jun; 197(6):626-637. PubMed ID: 35192719
[TBL] [Abstract][Full Text] [Related]
12. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
13. IGRT and motion management during lung SBRT delivery.
Caillet V; Booth JT; Keall P
Phys Med; 2017 Dec; 44():113-122. PubMed ID: 28647449
[TBL] [Abstract][Full Text] [Related]
14. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
15. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motion.
Boggs DH; Feigenberg S; Walter R; Wissing D; Patel B; Wu T; Rosen L
J Med Imaging Radiat Oncol; 2014 Dec; 58(6):706-13. PubMed ID: 24767098
[TBL] [Abstract][Full Text] [Related]
17. Analysis of intrafractional organ motion by megavoltage computed tomography in patients with lung cancer treated with image-guided stereotactic body radiotherapy using helical tomotherapy.
Aibe N; Yamazaki H; Nishimura T; Oota Y; Iwama K; Nakamura S; Ikeno H; Yoshida K; Okabe H; Yamada K
Anticancer Res; 2014 Dec; 34(12):7383-8. PubMed ID: 25503177
[TBL] [Abstract][Full Text] [Related]
18. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
[TBL] [Abstract][Full Text] [Related]
19. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).
Regnery S; Ristau J; Weykamp F; Hoegen P; Sprengel SD; Paul KM; Buchele C; Klüter S; Rippke C; Renkamp CK; Pohl M; Meis J; Welzel T; Adeberg S; Koerber SA; Debus J; Hörner-Rieber J
Radiat Oncol; 2022 May; 17(1):102. PubMed ID: 35614486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
